Urinary 3-(3-Hydroxyphenyl)-3-hydroxypropionic Acid, 3-Hydroxyphenylacetic Acid, and 3-Hydroxyhippuric Acid Are Elevated in Children with Autism Spectrum Disorders

BioMed Research International

Volumn 2016, Issue , 2016, Pages

  Xiong, Xiyue ^a   Liu, Dan ^a   Wang, Yichao ^a   Zeng, Ting ^a   Peng, Ying ^a  

^a Maternal and Child Health Care Hospital of Hunan Province   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (3 HYDROXYPHENYL) 3 HYDROXYPROPIONIC ACID; 3 HYDROXYHIPPURIC ACID; 3 HYDROXYPHENYLACETIC ACID; HIPPURIC ACID DERIVATIVE; HYDRACRYLIC ACID DERIVATIVE; UNCLASSIFIED DRUG; VANCOMYCIN; 3-(3-HYDROXYPHENYL)-3-HYDROXYPROPANOIC ACID; 3-HYDROXYBENZENEACETIC ACID; 3-HYDROXYHIPPURIC ACID; BIOLOGICAL MARKER; PHENYLACETIC ACID DERIVATIVE; PHENYLPROPIONIC ACID DERIVATIVE;

ARTICLE; AUTISM; CHILD; CLOSTRIDIUM; CONTROLLED STUDY; FEMALE; HUMAN; INTESTINE FLORA; MAJOR CLINICAL STUDY; MALE; METABOLOMICS; SENSITIVITY AND SPECIFICITY; URINARY EXCRETION; URINE LEVEL; AUTISM SPECTRUM DISORDER; CHINA; INFANT; PRESCHOOL CHILD; PREVALENCE; REPRODUCIBILITY; RISK FACTOR; URINE;

AUTISM SPECTRUM DISORDER; BIOMARKERS; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; HIPPURATES; HUMANS; INFANT; MALE; PHENYLACETATES; PHENYLPROPIONATES; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 84971492700     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2016/9485412     Document Type: Article

References (21)

1. A. Bailey, W. Phillips, and M. Rutter, "Autism: towards an integration of clinical, genetic, neuropsychological, and neurobiological perspectives, " Journal of Child Psychology and Psychiatry, vol. 37, no. 1, pp. 89-126, 1996.
2. M. Elsabbagh, G. Divan, Y.-J. Koh et al., "Global prevalence of autism and other pervasive developmental disorders, " Autism Research, vol. 5, no. 3, pp. 160-179, 2012.
3. J. Hallmayer, S. Cleveland, A. Torres et al., "Genetic heritability and shared environmental factors among twin pairs with autism, " Archives of General Psychiatry, vol. 68, no. 11, pp. 1095-1102, 2011.
4. S. M. Finegold, D. Molitoris, Y. Song et al., "Gastrointestinal microflora studies in late-onset autism, " Clinical Infectious Diseases, vol. 35, supplement 1, pp. S6-S16, 2002.
5. Y.-J. Zhang, S. Li, R.-Y. Gan, T. Zhou, D.-P. Xu, and H.-B. Li, "Impacts of gut bacteria on human health and diseases, " International Journal of Molecular Sciences, vol. 16, no. 4, pp. 7493-7519, 2015.
6. Y. Song, C. Liu, and S. M. Finegold, "Real-time PCR quantitation of clostridia in feces of autistic children, " Applied and Environmental Microbiology, vol. 70, no. 11, pp. 6459-6465, 2004.
7. H. M. R. T. Parracho, M. O. Bingham, G. R. Gibson, and A. L. McCartney, "Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children, " Journal of Medical Microbiology, vol. 54, no. 10, pp. 987-991, 2005.
8. J. B. Adams, L. J. Johansen, L. D. Powell, D. Quig, and R. A. Rubin, "Gastrointestinal flora and gastrointestinal status in children with autism comparisons to typical children and correlation with autismseverity, " BMC Gastroenterology, vol. 11, pp. 11-22, 2011.
9. W. Shaw, "Increased urinary excretion of a 3-(3-hydroxyphenyl)-3-hydroxypropionic acid (HPHPA), an abnormal phenylalanine metabolite of Clostridia spp. in the gastrointestinal tract, in urine samples from patients with autism and schizophrenia, " Nutritional Neuroscience, vol. 13, no. 3, pp. 135-143, 2010.
10. L. Altieri, C. Neri, R. Sacco et al., "Urinary p-cresol is elevated in small childrenwith severe autismspectrumdisorder, " Biomarkers, vol. 16, no. 3, pp. 252-260, 2011.
11. S. Gabriele, R. Sacco, L. Altieri et al., "Slow intestinal transit contributes to elevate urinary p-cresol level in Italian autistic children, " Autism Research, 2015.
12. S. Gabriele, R. Sacco, S. Cerullo et al., "Urinary p-cresol is elevated in young French children with autism spectrum disorder: a replication study, " Biomarkers, vol. 19, no. 6, pp. 463-470, 2014.
13. R. Keşli, C. Gökçen, U. Bulug, and Y. Terzi, "Investigation of the relation between anaerobic bacteria genus clostridium and lateonset autism etiology in children, " Journal of Immunoassay & Immunochemistry, vol. 35, no. 1, pp. 101-109, 2014.
14. L. Wang, M. A. Conlon, C. T. Christophersen, M. J. Sorich, and M. T. Angley, "Gastrointestinal microbiota and metabolite biomarkers in children with autism spectrum disorders, " Biomarkers in Medicine, vol. 8, no. 3, pp. 331-344, 2014.
15. X. Y. Xiong, X. Q. Sheng, D. Liu, T. Zeng, Y. Peng, and Y. C. Wang, "A GC/MS-based metabolomic approach for reliable diagnosis of phenylketonuria, " Analytical and Bioanalytical Chemistry, vol. 407, no. 29, pp. 8825-8833, 2015.
16. S. M. Finegold, "Therapy and epidemiology of autismclostridial spores as key elements, " Medical Hypotheses, vol. 70, no. 3, pp. 508-511, 2008.
17. R. H. Sandler, S. M. Finegold, E. R. Bolte et al., "Short-term benefit from oral vancomycin treatment of regressive-onset autism, " Journal of Child Neurology, vol. 15, no. 7, pp. 429-435, 2000.
18. R. Buck, J. Eberspächer, and F. Lingens, "Degradation and biosynthesis of L-phenylalanine by chloridazon-degrading bacteria, " Hoppe-Seyler's Zeitschrift für Physiologische Chemie, vol. 360, no. 7, pp. 957-969, 1979.
19. L. E. Dyck, C. W. Kazakoff, and C. T. Dourish, "The role of catecholamines, 5-hydroxytryptamine and m-tyramine in the behavioural effects of m-tyrosine in the rat, " European Journal of Pharmacology, vol. 84, no. 3-4, pp. 139-149, 1982.
20. S. Parrott, S. Jones, and R. A. Cooper, "2-Phenylethylamine catabolism by Escherichia coli K12, " Journal of General Microbiology, vol. 133, no. 2, pp. 347-351, 1987.
21. E. Diáz, A. Ferrández, M. A. Prieto, and J. L. Garciá, "Biodegradation of aromatic compounds by Escherichia coli, " Microbiology and Molecular Biology Reviews, vol. 65, no. 4, pp. 523-569, 2001.